A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices

Martin-Loeches, M.; Orti, R.; Monfort, Mélanie; Ortega, Emilio; Rius, Joan Sabrià

doi:10.1080/713604441

Cited by 9 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most favored pharmacologic intervention by OB/GYNs (recommended by 28%) was discontinuation or switching of the patient's oral contraceptive. This may reflect their clinical experience or published findings in some, but not all studies suggesting that oral contraceptives may adversely affect mood and sexual desire [29][30][31].…”

Section: Discussionmentioning

confidence: 91%

Management of Female Sexual Problems: Perceived Barriers, Practice Patterns, and Confidence among Primary Care Physicians and Gynecologists

Abdolrasulnia

Shewchuk

Roepke

et al. 2010

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Although approximately 40% of women report female sexual problems—and particularly sexual desire disorders, there are numerous practical, professional, and personal barriers to their diagnosis and management by treating clinicians. Aim To identify practice patterns, perceptions, and barriers to the diagnosis and management of female sexual problems among U.S. practicing primary care physicians (PCPs) and obstetrician/gynecologists (OB/GYNs). Methods A random sample of practicing U.S. PCPs and OB/GYNs were sent a case-vignette survey by e-mail and fax. Response to the survey was considered consent. A regression model was analyzed to assess predictors of confidence. Main Outcome Measure Frequency and variability in diagnostic tests ordered and treatment recommendations provided for a patient with diminished sexual desire. Percent of physicians who reported they were confident in treating hypoactive sexual desire disorder (HSDD) and percent who reported significant barriers to initiating a dialogue about sexual health with female patients. Results A total of 505 responses were analyzed (8.8% response rate). Of respondents, 21% of OB/GYNs and 38% of PCPs stated they were not at all confident in treating HSDD. The majority of physicians would order a thyroid panel (PCP=63%, OB/GYN=53%) to assess a patient’s diminished desire and recommended counseling and stress management to treat a patient with sexual complaints (PCP=48%, OB/GYN=54%). Regression results identified time constraints, the perceived lack of effective therapies, perceptions regarding patient-physician gender discordance, years in practice, number of patients seen per week, and perceptions regarding continuing medical education and practice experience as significant and independent predictors of confidence in treating HSDD patients. Conclusions Discussion of sexual health is difficult, but there are independent predictors of confidence in treating patients with decreased desire.

show abstract

Section: Discussionmentioning

confidence: 91%

Management of Female Sexual Problems: Perceived Barriers, Practice Patterns, and Confidence among Primary Care Physicians and Gynecologists

Abdolrasulnia

Shewchuk

Roepke

et al. 2010

The Journal of Sexual Medicine

View full text Add to dashboard Cite

show abstract

“…A maior freqüência de disfunções sexuais em mulheres que estavam amamentando poderia ser explicada pela ação inibidora da prolactina sobre a testosterona e consequentemente os estrógenos, visto que tanto a testosterona como a dehidrotestosterona são fortes precursores do estrogênio. 23 De fato, o grupo de mulheres que estava amamentando apresentou duas vezes mais chance de ter alguma disfunção sexual em comparação com as mulheres não lactantes.…”

Section: Discussionunclassified

Prevalência das disfunções sexuais femininas em clínica de planejamento familiar de um hospital escola no Recife, Pernambuco

Ferreira¹,

Souza²,

Amorim³

2007

Rev. Bras. Saude Mater. Infant.

View full text Add to dashboard Cite

OBJETIVOS: determinar a prevalência de disfunções sexuais femininas em mulheres atendidas no Centro de Atenção à Mulher do Instituto Materno Infantil Prof. Fernando Figueira, IMIP, utilizando os critérios de classificação da 4ª. edição do Manual Diagnóstico e Estatístico de Transtornos Mentais. MÉTODOS: estudo transversal, cujos dados foram obtidos em formulário estruturado, aplicado durante entrevista individual com 100 mulheres com idades entre 20 e 39 anos, no período de abril a maio de 2004. Determinou-se a freqüência das disfunções sexuais femininas e sua associação com as características biológicas, demográficas e reprodutivas das mulheres, assim como sua associação com o método contraceptivo usado no momento da entrevista. RESULTADOS: a prevalência de algum tipo de disfunção sexual foi de 36%. A disfunção do orgasmo foi constatada em 18% das entrevistadas e dispareunia em 13% das mulheres no último mês anterior ao estudo. A disfunção do desejo foi relatada por 11% das mulheres, 8% tiveram disfunção da excitação e apenas 1% referiram vaginismo. Observou-se uma associação positiva estatisticamente significativa das disfunções sexuais femininas com a idade da coitarca menor que 20 anos, freqüência de apenas uma relação sexual por semana ou menos e lactação. CONCLUSÕES: os achados sugerem que diversas medidas preventivas podem impedir a ocorrência de disfunções sexuais femininas em determinado grupo de pacientes: melhorar o nível educacional da população, facilitar seu acesso à informação e aconselhamento, estimular ações preventivas de saúde e por fim investir em programas de treinamento e educação médica continuada.

show abstract

“…Decreased sexual desire has been reported in 5% to 13% of COC users [5]. A more recent study [6] observed a similar decrease in sexual desire in approximately 10% of COC users. Although the mechanism of action of the COCs on sexual functioning is not known, one possibility is a reduction in free testosterone levels which affects sexual interest in women [7].…”

Section: Introductionmentioning

confidence: 86%

Comparison of Androgens in Women with Hypoactive Sexual Desire Disorder: Those on Combined Oral Contraceptives (COCs) vs. Those Not on COCs

Warnock

Clayton

Croft³

et al. 2006

The Journal of Sexual Medicine

View full text Add to dashboard Cite

Introduction Approximately one out of four sexually active women in the United States uses some form of hormonal contraceptive method because they provide the most effective reversible method of birth control available. However, little attention has been paid to possible adverse effects of combined oral contraceptives (COCs) on sexual functioning. Aims The aim of this study was to examine the potential effects of COCs on women with hypoactive sexual desire disorder (HSDD). It was hypothesized that female patients with generalized, acquired HSDD on COCs have lower androgen levels than those not on COCs. Methods The patients were healthy premenopausal women with HSDD, aged 22–50 years. Subjects had a history of adequate sexual desire, interest, and functioning. Participants were required to be in a stable, monogamous, heterosexual relationship and were screened for any medication or medical or psychiatric disorders that impact desire. The patients met operational criteria for global, acquired HSDD. The 106 patients were divided into two groups: those on COCs (N = 43) and those not on COCs (N = 63). A two-tailed t-test comparison was made between the two groups comparing free and total testosterone and sex hormone-binding globulin (SHBG). Main Outcome Measures The main outcome measures are the differences between the two groups comparing free testosterone, total testosterone, and SHBG. Results These patients with HSDD on COCs had significantly lower free and total testosterone levels compared with those who were not on COCs. The SHBG was significantly higher in the group on COCs compared with those who were not on COCs. Conclusion The result of this study suggests that COCs in premenopausal women with HSDD are associated with lower androgen levels than those not on COCs. Further research is required to determine if low androgen levels secondary to COCs impact female sexual desire.

show abstract

A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices

Cited by 9 publications

References 0 publications

Management of Female Sexual Problems: Perceived Barriers, Practice Patterns, and Confidence among Primary Care Physicians and Gynecologists

Management of Female Sexual Problems: Perceived Barriers, Practice Patterns, and Confidence among Primary Care Physicians and Gynecologists

Prevalência das disfunções sexuais femininas em clínica de planejamento familiar de um hospital escola no Recife, Pernambuco

Comparison of Androgens in Women with Hypoactive Sexual Desire Disorder: Those on Combined Oral Contraceptives (COCs) vs. Those Not on COCs

Contact Info

Product

Resources

About